Prevalence of Rifampicin-Resistant Tuberculosis among Patients Previously Treated for Pulmonary Tuberculosis in North-Western, Nigeria

BACKGROUND: Drug-resistant tuberculosis (TB) is a significant public health problem. Greater than 90% of rifampicin (RIF)-resistant isolates were also isoniazid resistant, and hence, rifampicin resistance (RR) is frequently used as a surrogate for multidrug-resistant TB. SETTING: This study was cond...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Niger Med J
Autors principals: Fadeyi, Abayomi, Desalu, Olufemi O., Ugwuoke, Chidi, Opanwa, Oji A., Nwabuisi, Charles, Salami, Alakija K.
Format: Artigo
Idioma:Inglês
Publicat: Wolters Kluwer - Medknow 2017
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6555224/
https://ncbi.nlm.nih.gov/pubmed/31198269
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/nmj.NMJ_41_17
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars